This is a demo store. No orders will be fulfilled.

PF-3845, 脂肪酸酰胺水解酶抑制剂

FAAH Inhibitors
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
P408694-1ml
1ml 现货 Stock Image
查看相关系列
Compound libraries (12333)

基本描述

英文别名 4-(3-(5-(trifluoromethyl)pyridin-2-yloxy)benzyl)-N-(pyridin-3-yl)piperidine-1-carboxamide
规格或纯度 Moligand™, 10mM in DMSO
英文名称 PF-3845
生化机理 PF-3845 是一种强效、选择性和不可逆的 FAAH 抑制剂,Ki为 230 nM,对 FAAH2 的活性微乎其微。
储存温度 -80℃储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 脂肪酸酰胺水解酶抑制剂
产品介绍

PF-3845是一种有效的,选择性的,不可逆的FAAH抑制剂,Ki为230 nM,对FAAH2几乎没有作用活性。A selective fatty acid amide hydrolase (FAAH) inhibitor.

Information

PF-3845 PF-3845 is a potent, selective and irreversible FAAH inhibitor with K i of 230 nM, showing negligible activity against FAAH2.
In vitro

PF-3845 selectively inhibits FAAH by carbamylating FAAH\'s serine nucleophile.

In vivo

PF-3845 treated mice (10 mg/kg, i.p.) shows rapid and complete inactivation of FAAH in the brain, as judged by competitive activity-based protein profiling (ABPP) with the serine hydrolase-directed probe fluorophosphonate (FP)-rhodamine. PF-3845 shows a long duration of action up to 24 hour. PF-3845-treated mice also shows dramatic (>10-fold) elevation in brain levels of AEA and other NAEs (N-pamitoyl ethanolamine [PEA] and N-oleoyl ethanolamine [OEA]). FAAH is AEA-degrading enzyme fatty acid amide hydrolase. PF-3845 (1–30 mg/kg, oral administration [p.o.]) causes a dose dependent inhibition of mechanical allodynia with a minimum effective dose (MED) of 3 mg/kg (rats are analyzed at 4 hour post dosing with PF-3845). At higher doses (10 and 30 mg/kg), PF-3845 inhibits pain responses to an equivalent, if not greater,degree than the nonsteroidal anti-inflammatory drug naproxen (10mg/kg, p.o.). PF-3845 (10 mg/kg, i.p.) significantly reverses LPS-induced tactile allodynia, but doesn\'t modify paw withdrawal thresholds in the saline-injected paw.
Cell Data

cell lines:NCI-H929, U266, RPMI-8226 and OPM2 MM cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

关联靶点(人)

FAAH Tchem 脂肪酸酰胺水解酶1(Fatty-acid amide hydrolase 1) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

分子类型 小分子
Isomeric SMILES C1CN(CCC1CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=CN=CC=C4
Reaxy-Rn 20599234
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=20599234&ln=

安全和危险性(GHS)

象形图 GHS06
信号词 Danger
危险声明

H301: 吞咽会中毒

预防措施声明

P301+P310: 如误吞咽:立即呼叫急救中心/医生。

WGK Germany 3

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器